Literature DB >> 8563789

Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation.

H Hampel1, F Müller-Spahn, C Berger, A Haberl, M Ackenheil, C Hock.   

Abstract

Serum and cerebrospinal fluid (CSF) from 44 patients with clinical probable Alzheimer's disease (AD) (subdivided in two groups with 18 early onset, EO, and 26 late onset, LO, cases), 10 patients with vascular dementia (VD) and 24 patients with major depression (MD) were assayed for concentrations of albumin and IgG. The severity of dementia was assessed with the Mini Mental State Examination. The CSF/serum ratio for albumin and IgG as well as the IgG index were used to evaluate blood-CSF barrier function. Various patients showed signs of blood-CSF-barrier (BCB) dysfunction and only few displayed evidence of local IgG synthesis in the central nervous system (CNS) in the AD, VD and in the MD group (IgG index > 0.7). The permeability of the blood-CSF barrier was not correlated to measures of dementia severity. Our data support the hypothesis of a BCB leakage in a subgroup of all investigated patients. Furthermore, we found a small number of patients with increased intrathecal IgG synthesis. Elevated CSF immunoglobulins combined with BCB impairment might be associated or caused by a general immune activation. Our data are in agreement with the assumption that an inflammatory process may play a role in a subgroup of patients with AD but also with MD and less likely in VD. In conclusion BCB impairment and elevated IgG immunoglobulin levels are unspecific either for AD, VD or MD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8563789     DOI: 10.1159/000106969

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  10 in total

1.  Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases.

Authors:  Sarah Jesse; Johannes Brettschneider; Sigurd D Süssmuth; Bernhard G Landwehrmeyer; Christine A F von Arnim; Albert C Ludolph; Hayrettin Tumani; Markus Otto
Journal:  J Neurol       Date:  2010-12-25       Impact factor: 4.849

Review 2.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Authors:  Raj N Kalaria
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 3.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

4.  Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.

Authors:  J Brettschneider; A Claus; J Kassubek; H Tumani
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

5.  Monomeric C-reactive protein induces the cellular pathology of Alzheimer's disease.

Authors:  Qini Gan; Alfred Wong; Zhengrong Zhang; Hana Na; Hua Tian; Qiushan Tao; Ibraheem M Rajab; Lawrence A Potempa; Wei Qiao Qiu
Journal:  Alzheimers Dement (N Y)       Date:  2022-07-08

6.  Extraordinary changes in excitatory amino acid levels in cerebrospinal fluid of influenza-associated encephalopathy of children.

Authors:  Hisashi Kawashima; Tsuneo Morishima; Takehiro Togashi; Shunpei Yokota; Gaku Yamanaka; Hiroaki Ioi; Yasuyo Kashiwagi; Kouji Takekuma; Akinori Hoshika; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

7.  Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain.

Authors:  John Anagli; Kadija Abounit; Paul Stemmer; Yuxia Han; Lisa Allred; Shantel Weinsheimer; Ashkhen Movsisyan; Donald Seyfried
Journal:  Biochem Biophys Res Commun       Date:  2007-12-03       Impact factor: 3.575

8.  Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression.

Authors:  Iciar Gárate; Borja García-Bueno; José L M Madrigal; Lidia Bravo; Esther Berrocoso; Javier R Caso; Juan A Micó; Juan C Leza
Journal:  J Neuroinflammation       Date:  2011-11-03       Impact factor: 8.322

Review 9.  Dementia and its implications for public health.

Authors:  Daniel P Chapman; Sheree Marshall Williams; Tara W Strine; Robert F Anda; Margaret J Moore
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

Review 10.  Waste Clearance in the Brain and Neuroinflammation: A Novel Perspective on Biomarker and Drug Target Discovery in Alzheimer's Disease.

Authors:  Kazuhiko Uchida
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.